High response of second-line chemotherapy with pemetrexed or gemcitabine combined with carboplatin in patients with non-small-cell lung cancer experiencing progression following 6 months after concluding platinum-based chemotherapy

By Arrieta Oscar  

Medical Oncology, Vol. 28, Iss. 1, 2011-03 ,pp. : 300-306

Humana Press, Inc

Access to resources Recommend Favorite

Long-term Follow-up of a Randomised Trial of Combined Chemoradiotherapy Induction Treatment, With and Without Maintenance Chemotherapy in Patients with Small Cell Carcinoma of the Lung

By Beith J.M.   Clarke S.J.   Woods R.L.   Bell D.R.   Levi J.A.  

European Journal of Cancer, Vol. 32, Iss. 3, 1996-03 ,pp. : 438-443

Elsevier

Access to resources Recommend Favorite

Paclitaxel, cisplatin, etoposide combination chemotherapy: a multifractionated bolus dose schedule for non-small cell lung cancer

By Lokich J.   Anderson N.   Bern M.   Coco F.   Gotthardt S.   Oliynyk P.   Dow E.  

European Journal of Cancer, Vol. 34, Iss. 5, 1998-04 ,pp. : 659-663

Elsevier

Access to resources Recommend Favorite

Mid-course thoracic radiotherapy with cisplatin-etoposide chemotherapy in limited-stage small-cell lung cancer

By Akyurek Serap   Onal Cem   Cagar Aysun   Hicsonmez Ayse   Andrieu Meltem   Kurtman Cengiz  

Medical Oncology, Vol. 23, Iss. 4, 2006-12 ,pp. : 499-505

Humana Press, Inc

Access to resources Recommend Favorite

Neutropenic enterocolitis during first-line chemotherapy with carboplatin and etoposide in small cell lung cancer

By Baandrup Louise   Hauggaard Anders   Winberg Birgitte H.   Holm Bente  

Acta Oncologica, Vol. 50, Iss. 3, 2011-04 ,pp. : 465-467

Informa Healthcare

Access to resources Recommend Favorite